Demonstration and characterization of mutations induced by Helicobacter pylori organisms in gastric epithelial cells

Helicobacter

Volumn 11, Issue 4, 2006, Pages 272-286

  Yao, Yuan ^a   Tao, Hong ^a   Dong, Il Park ^a,b   Sepulveda, Jorge L ^a   Sepulveda, Antonia R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cancer; CpG methylation; DNA mismatch repair; Helicobacter; Mutations

Indexed keywords

GREEN FLUORESCENT PROTEIN; PLASMID VECTOR; PROTEIN SUBUNIT;

ARTICLE; CANCER RISK; CELL COUNT; CELL CULTURE; CHRONIC GASTRITIS; CONTROLLED STUDY; CPG ISLAND; DATA ANALYSIS; DISEASE ASSOCIATION; EPIGENETICS; EPITHELIUM CELL; ESCHERICHIA COLI; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC TRANSFECTION; GENOME; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INFLAMMATION; MEASUREMENT; METHYLATION; MISMATCH REPAIR; MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE; COCULTURE TECHNIQUES; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EPITHELIAL CELLS; ESCHERICHIA COLI; GASTRIC MUCOSA; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HELICOBACTER PYLORI; HUMANS; MUTAGENESIS; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANSFECTION;

ESCHERICHIA COLI; HELICOBACTER PYLORI;

EID: 33745905305     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2006.00408.x     Document Type: Article

References (52)

1. International Agency for Research on Cancer (IARC). Live flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon. 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
2. Huang JQ, Sridhar S, Chen Y, et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-79.
3. Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642-8.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
5. Villako K, Kekki M, Maaroos HI, et al. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol Suppl 1991;186:135-41.
6. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996;56:3238-43.
7. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
8. Sepulveda A, Peterson LE, Shelton J, et al. Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancer. Am J Gastroenterol 2002;97:1365-70.
9. Asaka M, Dragosics BA. Helicobacter pylori and gastric malignancies. Helicobacter 2004;9:35-41.
10. Leung SY, Yuen ST, Chung LP, et al. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999;59:159-64.
11. Waki T, Tamura G, Tsuchiya T, et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002;161:399-403.
12. Leung WK, Yu J, Ng EK, et al. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 2001;91:2294-301.
13. Kang GH, Lee S, Kim JS, et al. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest 2003;83:635-41.
14. Arabski M, Klupinska G, Chojnacki J, et al. DNA damage and repair in Helicobacter pylori-infected gastric mucosa cells. Mutat Res 2005;570:129-35.
15. Xu H, Chaturvedi R, Cheng Y, et al. Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 2004;64:8521-5.
16. Ladeira MS, Rodrigues MA, Salvadori DM, et al. Relationships between cagA, vacA, and iceA genotypes of Helicobacter pylori and DNA damage in the gastric mucosa. Environ Mol Mutagen 2004;44:91-8.
17. Touati E, Michel V, Thiberge JM, et al. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 2003;124:1408-19.
18. Kim JJ, Tao H, Carloni B, et al. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002;123:542-53.
19. Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori: associated gastric carcinogenesis. Clin Lab Med 2005;25:197-222.
20. Leung WK, Kim JJ, Kim JG et al. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 2000;156:537-43.
21. Park DI, Park SH, Kim SH, et al. Effect of Helicobacter pylori infection on the expression of DNA mismatch repair protein. Helicobacter 2005;10:179-84.
22. Yamaoka Y, Kikuchi S, el-Zimaity HM, et al. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002;123:414-24.
23. Fujikawa A, Shirasaka D, Yamamoto S, et al. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 2003;33:375-81.
24. Sepulveda AR, Tao H, Carloni E, et al. Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment Pharmacol Ther 2002;16:145-57.
25. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999;9:89-96.
26. Chang DK, Ricciardiello L, Goel A, et al. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 2000;275:29178.
27. Leung WK, Kim JJ, Wu L, et al. Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells. J Biol Chem 2000;275:15728-32.
28. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med 1996;2:169-74.
29. Baek MJ, Kang H, Kim SE, et al. Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer 2001;85:1147-52.
30. Fleisher AS, Esteller M, Tamura G, et al. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 2001;20:329-35.
31. Park JG, Yang HK, Kim WH, et al. Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 1997;70:443-9.
32. Hausner P, Venzon DJ, Grogan L, et al. The 'comparative growth assay': examining the interplay of anti-cancer agents with cells carrying single gene alterations. Neoplasia 1999;1:356-67.
33. Gologan A, Krasinskas A, Hunt J, et al. Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Arch Pathol Lab Med 2005;129:1390-7.
34. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998;95:6870-5.
35. Hite JM, Eckert KA, Cheng KC. Factors affecting fidelity of DNA synthesis during PCR amplification of d (C-A)nd(G-T)n microsatellite repeats. Nucleic Acids Res 1996;24:2429-34.
36. Ahmed A, Smoot D, Littleton G, et al. Helicobacter pylori inhibits gastric cell cycle progression. Microbes Infect 2000;2:1159-69.
37. Sommi P, Savio M, Stivala LA, et al. Helicobacter pylori releases a factor(s) inhibiting cell cycle progression of human gastric cell lines by affecting cyclin E/cdk2 kinase activity and Rb protein phosphorylation through enhanced p27 (KIP1) protein expression. Exp Cell Res 2002;281:128-39.
38. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
39. Farinati F, Cardin R, Degan P, et al. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 1998;42:351-6.
40. Hunt JD, Mera R, Strimas A, et al. KRAS mutations are not predictive for progression of preneoplastic gastric lesions. Cancer Epidemiol Biomarkers Prev 2001;10:79-80.
41. Hiyama T, Haruma K, Kitadai Y, et al. K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 2002;97:562-6.
42. Kobayashi K, Okamoto T, Takayama S, et al. Genetic instability in intestinal metaplasia is a frequent event leading to well-differentiated early adenocarcinoma of the stomach. Eur J Cancer 2000;36:1113-9.
43. dos Santos NR, Seruca R, Constancia M, et al. Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology 1996;110:38-44.
44. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-9.
45. Ottini L, Falchetti M, D'Amico C, et al. Mutations at coding mononucleotide repeats in gastric cancer with the microsatellite mutator phenotype. Oncogene 1998;16:2767-72.
46. Pinto M, Oliveira C, Cirnes L, et al. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas. J Pathol 2003;200:32-8.
47. Flores-Rozas H, Kolodner RD. The Saccharomyces cerevisiae MLH3 gene functions in MSH3-dependent suppression of frameshift mutations. Proc Natl Acad Sci U S A 1998;95:12404-9.
48. Peek RM Jr, Blaser MJ, Mays DJ et al. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res 1999;59:6124-31.
49. Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carcinogenesis. Gastroenterol Clin North Am 2002;31:517-35.
50. Maeda S, Yoshida H, Ogura K, et al. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 2000;119:97-108.
51. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int 2000;50:767-77.
52. Yao Y, Tao H, Kim JJ, et al. Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines. Lab Invest 2004;84:915-22.